Please login to the form below

Not currently logged in
Email:
Password:

Signifor

This page shows the latest Signifor news and features for those working in and with pharma, biotech and healthcare.

FDA approves Recordati’s Cushing disease drug Isturisa

FDA approves Recordati’s Cushing disease drug Isturisa

Signifor and its longer-acting follow-up Signifor LAR – both based on the somatostatin analogue pasireotide. ... That would add to pro forma sales of around $75m last year for the Signifor franchise, with potential to raise that to $100m, he said.

Latest news

  • Novartis' acromegaly therapy cleared by FDA Novartis' acromegaly therapy cleared by FDA

    In trials, Signifor LAR showed superior efficacy to older somatostatin analogues, as measured by higher rates of biochemical control of GH and IGF-1 levels. ... Signifor LAR needs to be given just once a month, allowing it to compete head-to-head with

  • Novartis gets EU nod for rare disease drug Signifor Novartis gets EU nod for rare disease drug Signifor

    This first approval of Signifor in acromegaly marks a much needed advance in the treatment of this rare disease.". ... Signifor LAR has been submitted worldwide for the treatment of acromegaly, with an application filed in the US earlier this year, said

  • Novartis plans filings for acromegaly candidate Novartis plans filings for acromegaly candidate

    Could add to Signifor’s indications. A phase III trial of Novartis' somatostatin analogue Signifor has suggested it could be effective for the growth hormone disorder acromegaly. ... The shorter-acting, subcutaneous form of Signifor was approved in 2012

  • Novartis cancer chief Hoppenot leaves for top job at Incyte Novartis cancer chief Hoppenot leaves for top job at Incyte

    During his time at the helm of Novartis' cancer division Hoppenot presided over the launch of two new cancer therapies, Jakavi for myelofibrosis in 2011 and Signifor (pasireotide) for Cushing's

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics